Mesenchymal stem cell transplantation in limbal stem cell deficiency – Development of precision medicine
Limbal stem cell deficiency (LSCD) causes discomfort and reduced vision and is a major problem in ophthalmology. Today, the treatment is transplantation of allogenic limbal stem cells, but this has its limitations.
Mesenchymal stem cells are now emerging as a promising treatment option. The phase 1 clinical trial using these cells in patients with end-stage LSCD will be presented.
Cecilie Bredrup, MD, PhD at HUH og Associate professor at K1, UiB
30th of August, 14.30-15.30
Birkhaugsalen, 3rd floor in Sentralblokken, HUH
Welcome to the first seminar this semester in the seminar series of Mohn Research Center for Regenerative Medicine (MRCRM)!
This seminar is open to all. Light refreshments will be served.